_version_ 1783729586180194304
author Ohmura, Shunya
Marchetto, Aruna
Orth, Martin F.
Li, Jing
Jabar, Susanne
Ranft, Andreas
Vinca, Endrit
Ceranski, Katharina
Carreño-Gonzalez, Martha J.
Romero-Pérez, Laura
Wehweck, Fabienne S.
Musa, Julian
Bestvater, Felix
Knott, Maximilian M. L.
Hölting, Tilman L. B.
Hartmann, Wolfgang
Dirksen, Uta
Kirchner, Thomas
Cidre-Aranaz, Florencia
Grünewald, Thomas G. P.
author_facet Ohmura, Shunya
Marchetto, Aruna
Orth, Martin F.
Li, Jing
Jabar, Susanne
Ranft, Andreas
Vinca, Endrit
Ceranski, Katharina
Carreño-Gonzalez, Martha J.
Romero-Pérez, Laura
Wehweck, Fabienne S.
Musa, Julian
Bestvater, Felix
Knott, Maximilian M. L.
Hölting, Tilman L. B.
Hartmann, Wolfgang
Dirksen, Uta
Kirchner, Thomas
Cidre-Aranaz, Florencia
Grünewald, Thomas G. P.
author_sort Ohmura, Shunya
collection PubMed
description
format Online
Article
Text
id pubmed-8314608
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83146082021-07-28 Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma Ohmura, Shunya Marchetto, Aruna Orth, Martin F. Li, Jing Jabar, Susanne Ranft, Andreas Vinca, Endrit Ceranski, Katharina Carreño-Gonzalez, Martha J. Romero-Pérez, Laura Wehweck, Fabienne S. Musa, Julian Bestvater, Felix Knott, Maximilian M. L. Hölting, Tilman L. B. Hartmann, Wolfgang Dirksen, Uta Kirchner, Thomas Cidre-Aranaz, Florencia Grünewald, Thomas G. P. Mol Cancer Letter to the Editor BioMed Central 2021-07-27 /pmc/articles/PMC8314608/ /pubmed/34315482 http://dx.doi.org/10.1186/s12943-021-01393-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Ohmura, Shunya
Marchetto, Aruna
Orth, Martin F.
Li, Jing
Jabar, Susanne
Ranft, Andreas
Vinca, Endrit
Ceranski, Katharina
Carreño-Gonzalez, Martha J.
Romero-Pérez, Laura
Wehweck, Fabienne S.
Musa, Julian
Bestvater, Felix
Knott, Maximilian M. L.
Hölting, Tilman L. B.
Hartmann, Wolfgang
Dirksen, Uta
Kirchner, Thomas
Cidre-Aranaz, Florencia
Grünewald, Thomas G. P.
Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
title Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
title_full Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
title_fullStr Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
title_full_unstemmed Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
title_short Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
title_sort translational evidence for rrm2 as a prognostic biomarker and therapeutic target in ewing sarcoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314608/
https://www.ncbi.nlm.nih.gov/pubmed/34315482
http://dx.doi.org/10.1186/s12943-021-01393-9
work_keys_str_mv AT ohmurashunya translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT marchettoaruna translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT orthmartinf translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT lijing translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT jabarsusanne translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT ranftandreas translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT vincaendrit translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT ceranskikatharina translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT carrenogonzalezmarthaj translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT romeroperezlaura translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT wehweckfabiennes translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT musajulian translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT bestvaterfelix translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT knottmaximilianml translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT holtingtilmanlb translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT hartmannwolfgang translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT dirksenuta translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT kirchnerthomas translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT cidrearanazflorencia translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma
AT grunewaldthomasgp translationalevidenceforrrm2asaprognosticbiomarkerandtherapeutictargetinewingsarcoma